We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Scotiabank
BNS
$106B
| $6M | 0.16% |
151,678
+143,678
| +1,796% | +$6.2M |
|
|
ANDV
102
DELISTED
Andeavor
ANDV
| $5.93M | 0.16% |
56,248
+43,511
| +342% | +$4.69M |
|
103
Sprott Physical Gold and Silver Trust
CEF
$7.43B
| $5.77M | 0.15% |
577,929
+137,929
| +31% | +$1.46M |
|
104
O'Reilly Automotive
ORLY
$72.4B
| $5.71M | 0.15% |
338,055
-192,345
| -36% | -$3.34M |
|
105
Keurig Dr Pepper
KDP
$40.4B
| $5.63M | 0.15% |
+60,463
| New | +$5.36M |
|
106
Charter Communications
CHTR
$14.7B
| $5.59M | 0.15% |
30,534
-8,182
| -21% | -$1.51M |
|
|
VMW
107
CALL
DELISTED
VMware, Inc
VMW
| $5.54M | 0.15% |
98,000
+50,000
| +104% | +$3.11M |
|
108
Coca-Cola Europacific Partners
CCEP
$46.5B
| $5.51M | 0.15% |
111,946
-94,344
| -46% | -$4.75M |
|
109
Cigna
CI
$76.6B
| $5.5M | 0.15% |
37,607
+33,984
| +938% | +$4.67M |
|
110
United Therapeutics
UTHR
$26.3B
| $5.47M | 0.14% |
34,956
+32,709
| +1,456% | +$4.76M |
|
111
Stryker
SYK
$127B
| $5.41M | 0.14% |
58,191
+15,205
| +35% | +$1.46M |
|
112
Alkermes
ALKS
$8.82B
| $5.41M | 0.14% |
68,092
-2,976
| -4% | -$208K |
|
113
American Express
AXP
$223B
| $5.36M | 0.14% |
77,018
+58,121
| +308% | +$4.23M |
|
114
Edwards Lifesciences
EW
$47.6B
| $5.28M | 0.14% |
200,646
+140,016
| +231% | +$3.64M |
|
|
115
PUT
Regeneron Pharmaceuticals
REGN
$68.8B
| $5.21M | 0.14% |
9,600
-101,400
| -91% | -$54.9M |
|
|
TVPT
116
DELISTED
Travelport Worldwide Limited
TVPT
| $5.16M | 0.14% |
399,658
-195,388
| -33% | -$2.68M |
|
117
Boeing
BA
$165B
| $5.13M | 0.14% |
35,460
-10,335
| -23% | -$1.49M |
|
|
DD
118
DELISTED
Du Pont De Nemours E I
DD
| $5.08M | 0.13% |
76,242
+68,376
| +869% | +$4.34M |
|
119
Rimini Street
RMNI
$408M
| $5.04M | 0.13% |
+524,100
| New | +$5.04M |
|
120
Bruker
BRKR
$9.2B
| $5.02M | 0.13% |
206,759
+190,280
| +1,155% | +$3.95M |
|
|
CAM
121
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $4.95M | 0.13% |
78,355
+10,190
| +15% | +$674K |
|
|
122
PUT
Charter Communications
CHTR
$14.7B
| $4.94M | 0.13% |
27,000
| – | – |
|
123
CALL
Alcoa
AA
$11.7B
| $4.93M | 0.13% |
208,073
+116,521
| +127% | +$2.6M |
|
|
GAS
124
DELISTED
AGL Resources Inc
GAS
| $4.92M | 0.13% |
77,100
-25,511
| -25% | -$1.59M |
|
125
Canadian National Railway
CNI
$78.3B
| $4.91M | 0.13% |
87,792
+83,964
| +2,193% | +$4.91M |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
BWP
MC
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.